Pet imaging in the baltimore longitudinal study of aging (blsa)
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95023D00015
- Awardee
-
Chesapeake Open Mri, LLC UEI N1YBBZKGLK85
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $860,080 obligated
Award facts
- Opportunity
-
- Early Markers of Alzheimer’s Disease: PET Radiotracer Acquisition in the Baltimore Longitudinal Study of Aging (BLSA) Pre-Solicitation · 75N95023Q00150 · Posted Dec 13, 2022
- Combined order value
- $860,080 Current and potential, with all options
- Last date to order 62% complete
- IDV ceiling 21% used
- $4,164,475.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- National Institute on Aging National Institutes of Health, Department of Health and Human Services
- NAICS code
- 621512 Diagnostic Imaging Centers
- PSC
- Q522 Medical- Radiology
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institutes of Health National Institute on Aging awarded a single award indefinite delivery contract to Chesapeake Open MRI, LLC doing business as Chesapeake Medical Imaging with a potential value of $4.16M. The contract provides for the acquisition of positron emission tomography radioligand doses to support amyloid and tau imaging in the Baltimore Longitudinal Study of Aging.
Under the contract, Chesapeake Medical Imaging will supply FDA-approved amyloid and second generation tau PET radioligand doses in minimum and maximum amounts on an annual basis through September 2028. An initial $405K firm fixed price delivery order was also awarded for amyloid and tau PET scans to support research on aging through September 2024. Performance will take place in Cape St Claire, Maryland within 15 miles of the NIA Clinical Research Program at Harbor Hospital.
The contract aims to procure PET radiotracer doses to measure amyloid and tau neuropathology in vivo and support the National Institute on Aging's longitudinal brain imaging study of older adults. The study seeks to characterize individual differences in brain changes underlying cognitive aging and identify predictors of cognitive decline and Alzheimer's disease.
Task orders
Quick answers
Who was awarded contract 75N95023D00015?
75N95023D00015 was awarded to Chesapeake Open Mri, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 15, 2023.
How much is contract 75N95023D00015 worth?
Orders under 75N95023D00015 have obligated $860,080. 75N95023D00015's own ceiling is $4,164,475.
How many orders have been placed under contract 75N95023D00015?
3 orders have been placed under 75N95023D00015, the latest on September 15, 2024.
Which agency awarded contract 75N95023D00015?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95023D00015, with funding from National Institute on Aging (National Institutes of Health).
Who can order from contract 75N95023D00015?
75N95023D00015 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95023D00015 competed?
The extent of competition for 75N95023D00015 was competed under sap. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV